BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Monday, April 20, 2026
Home » Newsletters » BioWorld Science

BioWorld Science

Sep. 4, 2002

View Archived Issues

Muscle stem cells may be useful in the regeneration of dystrophic muscle

Read More

MedImmune to develop antibodies and vaccines against hMPV

Read More

Amsterdam Molecular Therapeutics licenses rights to IL-10 for ex vivo gene therapy

Read More

AERx iDMS enters phase III program

Read More

Pediatric indication approved for Zenapax

Read More

Pharmacodynamic and pharmacokinetic profile of fesoterodine

Read More

Potential new therapeutic for functional dyspepsia presented at medicinal chemistry meeting

Read More

Spanish investigators discover potent and selective inhibitor of the endocannabinoid transporter

Read More

SSR-69071 selected for development as an HLE inhibitor for respiratory diseases

Read More

Bladder-selective potassium channel openers described by Abbott and ICAgen

Read More

Orally active LH receptor agonist with efficacy in inducing ovulation in mice

Read More

Non-nephrotoxic AMPA antagonist S-34730-1 with potential in neurodegenerative diseases

Read More

Ezetimibe + statins consistently better than statin therapy alone

Read More

Keryx Biopharmaceuticals focuses resources on KRX-101 and KRX-123

Read More

Improved renal function associated with TA-0201 + enalapril in dogs with CHF

Read More

Tadalafil receives positive recommendation in Australia

Read More

FDA issues approvable letter for aripiprazole

Read More

Once-weekly risedronate approved in Sweden

Read More

Bayer and Boehringer Ingelheim sign letter of intent for marketing of telmisartan

Read More

A.P. Pharma withdraws APF-112 phase II protocol

Read More

Potential of fidarestat in diabetic retinopathy emerges from preclinical studies

Read More

Compounds with the ability to inhibit phosphorylation of STAT6 claimed by Pola

Read More

Merck & Co. discloses HIV integrase inhibitors

Read More

Compounds for glaucoma and ocular hypertension with improved profile over natural prostaglandins

Read More

Novel radiopharmaceuticals for imaging sites of infection and/or inflammation

Read More

Antibacterial carbapenems described by Sumitomo

Read More

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for April 17, 2026.
  • Man holding raised arm with illustrated overlay of nerves

    Biohaven reports details on discovery of BHV-2100

    BioWorld Science
    Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
  • New GABA(B) receptor PAMs revealed in Addex Pharma patents

    BioWorld Science
    Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
  • Elderly woman holding illustration of brain with missing puzzle piece

    Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’

    BioWorld
    The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
  • Novel caspase-2 inhibitor shows in vivo neuroprotective effects

    BioWorld Science
    Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing